Lenz & Staehelin advised Asceneuron in its Series C financing. Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Transmutex on all legal matters. Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension...
You must be a Standard 1 Year member to access this content.
Travers Smith LLP and Walder Wyss advised Inflexion on the deal. Lenz & Staehelin advised Gyrus Capital in this transaction. Inflexion and Gyrus Capital have announced...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Octium Group in this transaction. Octium Group, a leading provider of PPLI solutions, has agreed to acquire Insurevolution’s PPLI business of approximately...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Unilabs in this transaction. Wenger Vieli advised the shareholders of RIMED. Unilabs, a leading diagnostic services provider, and RIMED, a leading Swiss...
You must be a Standard 1 Year member to access this content.
